{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:11:42Z","timestamp":1792080702486,"version":"4.4.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":481,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Congestive heart failure (HF) is a common complication in patients with acute myocardial infarction (AMI). The estimated plasma volume status [ePVS = (100 \u2212 haematocrit)\/haemoglobin] is used as the blood plasma volume index to determine the presence of congestion in patients with HF. However, the clinical impact of ePVS at discharge in patients with AMI remains unclear. This study aimed to investigate whether ePVS at discharge could determine the long-term prognosis in patients with AMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We retrospectively identified patients with AMI with ePVS measured at discharge between January 2012 and December 2020. The primary endpoint was post-discharge all-cause death. The patients were divided into two groups according to an ePVS cut-off value of 5.5%, which is commonly used in HF. In total, 1012 patients with AMI were included. The median age was 70 years (range, 61\u201378 years), and 76.4% of the patients were male. The ePVS &amp;gt; 5.5% (high-ePVS) group included 365 patients (36.1%), and the all-cause mortality rate in the total cohort was 17.7%. The log-rank test revealed that the high-ePVS group had a significantly higher rate of all-cause death than the ePVS \u2264 5.5% (low-ePVS) group (P &amp;lt; 0.001). Multivariate Cox proportional hazards model analysis revealed that high ePVS was associated with post-discharge all-cause death, independent of other risk factors (hazard ratio = 1.879; 95% confidence interval = 1.343\u20132.629, P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High ePVS at discharge was independently associated with high post-discharge all-cause mortality in patients with AMI. Our study suggests that ePVS at discharge in patients with AMI could serve as a novel prognostic marker.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14912","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T01:23:46Z","timestamp":1719019426000},"page":"3222-3231","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic Value of Estimated Plasma Volume Status at Discharge in Acute Myocardial Infarction"],"prefix":"10.1093","volume":"11","author":[{"given":"Kazutaka","family":"Nogi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Nogi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Nakada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Seno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Onoue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]},{"name":"Department of Cardiovascular Medicine, Nara Prefecture Seiwa Medical Center , Sango ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungo","family":"Hikoso","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University , Kashihara ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"2026012113142672900_ehf214912-bib-0001","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","author":"Bahit","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026012113142672900_ehf214912-bib-0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100748","article-title":"Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction","volume":"33","author":"Kawai","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026012113142672900_ehf214912-bib-0003","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","article-title":"Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure","volume":"258","author":"Rubio-Gracia","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026012113142672900_ehf214912-bib-0004","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/ehf2.14301","article-title":"Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction","volume":"10","author":"Hamilton","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026012113142672900_ehf214912-bib-0005","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","article-title":"Congestion in acute heart failure syndromes: an essential target of evaluation and treatment","volume":"119","author":"Gheorghiade","year":"2006","journal-title":"Am J Med"},{"key":"2026012113142672900_ehf214912-bib-0006","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00392-020-01794-8","article-title":"Estimated plasma volume status in heart failure: clinical implications and future directions","volume":"110","author":"Kobayashi","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2026012113142672900_ehf214912-bib-0007","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025596","article-title":"New classification for the combined assessment of the fractional excretion of urea nitrogen and estimated plasma volume status in acute heart failure","volume":"12","author":"Nogi","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026012113142672900_ehf214912-bib-0008","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012113142672900_ehf214912-bib-0009","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jchf.2015.06.014","article-title":"Prognostic value of estimated plasma volume in heart failure","volume":"3","author":"Duarte","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026012113142672900_ehf214912-bib-0010","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02089953","article-title":"Clinical and pharmacological investigations of the new saluretic azosemid","volume":"14","author":"Kruck","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"key":"2026012113142672900_ehf214912-bib-0011","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1586\/erc.09.74","article-title":"TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure","volume":"7","author":"Diez","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012113142672900_ehf214912-bib-0012","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12872-022-02753-z","article-title":"Prognostic implications for patients after myocardial infarction: an integrative literature review and in-depth interviews with patients and experts","volume":"22","author":"Hwang","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012113142672900_ehf214912-bib-0013","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12872-017-0482-9","article-title":"Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review","volume":"17","author":"Johansson","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012113142672900_ehf214912-bib-0014","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012113142672900_ehf214912-bib-0015","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10741-014-9438-7","article-title":"Water and sodium in heart failure: a spotlight on congestion","volume":"20","author":"Parrinello","year":"2015","journal-title":"Heart Fail Rev"},{"key":"2026012113142672900_ehf214912-bib-0016","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrcardio.2011.154","article-title":"Cardiac remodeling at the population level\u2014risk factors, screening, and outcomes","volume":"8","author":"Gjesdal","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2026012113142672900_ehf214912-bib-0017","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11886-017-0876-4","article-title":"Adverse remodeling and reverse remodeling after myocardial infarction","volume":"19","author":"Bhatt","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"2026012113142672900_ehf214912-bib-0018","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/JAHA.116.005277","article-title":"Prognostic impact of in-hospital and postdischarge heart failure in patients with acute myocardial infarction: a nationwide analysis using data from the Cardiovascular Disease in Norway (CVDNOR) project","volume":"6","author":"Sulo","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026012113142672900_ehf214912-bib-0019","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012113142672900_ehf214912-bib-0020","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1111\/dom.13855","article-title":"Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes","volume":"21","author":"Dekkers","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2026012113142672900_ehf214912-bib-0021","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012113142672900_ehf214912-bib-0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101326","article-title":"Loop diuretic use is associated with adverse clinical outcomes in acute myocardial infarction patients with low volume status","volume":"47","author":"Kawai","year":"2022","journal-title":"Curr Probl Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/5\/3222\/64514959\/eschf_11_5_3222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/5\/3222\/64514959\/eschf_11_5_3222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:16:17Z","timestamp":1769019377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/5\/3222\/8271218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6,21]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14912","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"2024-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}